Correspondence 0001193125-24-174704 from PepGen Inc. (PEPG) (CIK 0001835597) (PEPG)
PepGen Inc. (PEPG) (CIK 0001835597)
Date: July 3, 2024 · CIK: 0001835597 · Accession: 0001193125-24-174704
AI Filing Summary & Sentiment
File numbers found in text: 333-280570
Letter
PepGen Inc.
321 Harrison Avenue, 8th Floor
Boston, Massachusetts 02118
July 3, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attn: Chris Edwards
Re: PepGen Inc.
Registration Statement on Form S-3 (File No. 333-280570)
Request for Acceleration of Effective Date
To whom it may concern:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, PepGen Inc. (the “Company”) hereby respectfully requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-280570), be accelerated by the Securities and Exchange Commission to 4:00 p.m. Eastern time, on July 8, 2024, or as soon thereafter as possible.
We request that we be notified of such effectiveness by a telephone call to Alicia M. Tschirhart of Goodwin Procter LLP at (415) 733 6156 and that such effectiveness also be confirmed in writing.
Very truly yours,
PepGen Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP PepGen Inc. 321 Harrison Avenue, 8th Floor Boston, Massachusetts 02118 July 3, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attn: Chris Edwards Re: PepGen Inc. Registration Statement on Form S-3 (File No. 333-280570) Request for Acceleration of Effective Date To whom it may concern: Pursuant to Rule 461 under the Securities Act of 1933, as amended, PepGen Inc. (the “Company”) hereby respectfully requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-280570), be accelerated by the Securities and Exchange Commission to 4:00 p.m. Eastern time, on July 8, 2024, or as soon thereafter as possible. We request that we be notified of such effectiveness by a telephone call to Alicia M. Tschirhart of Goodwin Procter LLP at (415) 733 6156 and that such effectiveness also be confirmed in writing. Very truly yours, PepGen Inc. By: /s/ James McArthur, Ph.D. Name: James McArthur, Ph.D. Title: Chief Executive Officer cc: Finnbarr Murphy, Goodwin Procter LLP Alicia M. Tschirhart, Goodwin Procter LLP